FDA to withdraw certain drug-related guidances with end of PHE
By
Alicia Lasek
Mar 14, 2023
The Food and Drug Administration has issued a notice detailing which COVID-19-related guidances will expire when the public health emergency ends as scheduled on May 11, and which guidances will remain...
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Vitamin D3 does not reduce fracture risk in healthy older adults: study
By
Alicia Lasek (f3)
Jul 29, 2022
Results from a large clinical trial do not support the use of vitamin D supplements to reduce fractures in generally healthy men and women, investigators say.
Risk of respiratory infection nearly 6 times higher in people with insomnia
By
Alicia Lasek
Jun 09, 2023
Chronic poor sleep is a risk factor for contracting influenza and other respiratory infections, and contributes to severity, a large study reveals.
Older adults’ care preferences honored, but inequities apparent, analysts find
By
Alicia Lasek
Jun 16, 2023
More adults are saying that their healthcare preferences are considered by their providers, a 9.5% increase from 2014 to 2020. But the data also highlight inequities, investigators say.
Known risk factors don’t explain vast contrasts in cognitive abilities as we age: study
By
Alicia Lasek
Feb 12, 2023
At age 54, key factors linked to cognitive abilities — such as education — explained only 38% of the variation in functioning among study participants.
Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
Dementia decline could be slowed by antiseizure meds in some cases, study finds
By
Alicia Lasek
Dec 05, 2022
The results revealed profound early decline among dementia patients with active seizures, including worse cognitive and mental health, and daily functioning.
Fatal outcome in trial of Alzheimer’s drug lecanemab raises patient safety concerns
By
Alicia Lasek
May 25, 2023
The findings highlight unresolved questions about how patients respond to this treatment, and how to best vet and advise recipients, investigators say.
Medicare eligibility comes with increase in tooth loss, Harvard study reveals
By
Alicia Lasek
Feb 10, 2023
When patients become eligible for Medicare coverage, restorative dental care immediately falls and tooth loss increases, a new study from Harvard University and Brigham and Women’s Hospital has found.